New Head of Institute and Managing Director
Dr Annette Burchardt has been the new Institute Director and Managing Director of InphA GmbH since 1 January 2024. She has taken over these responsibilities from Dr Tanja Pallmann, who …
Dr Annette Burchardt has been the new Institute Director and Managing Director of InphA GmbH since 1 January 2024. She has taken over these responsibilities from Dr Tanja Pallmann, who …
Active participation in the 28th Annual Meeting of the European Network of Official Medicines Control Laboratories from 5 to 9 June in Madrid. The event is hosted by the European …
InphA participated in the WHO Conference “Consultation on Quality Control and Pharmaceutical Specifications of Medicines” from 25 – 27 April in Geneva.Dr. Frank Höper presented laboratory results from the verifications …
Future Day 2023 at InphA! On 27.04.2023, seven pupils were able to get an idea of the training profession of a chemical laboratory assistant. Certainly not an everyday occurrence and …
On 1 October 2021, Dr Tanja Pallmann took over the management of InphA GmbH. She succeeds Dr Konrad Horn. Dr Pallmann holds a doctorate in pharmacy and has many years …
On 1 December 1995, the former AMI Arzneimitteluntersuchungsinstitut-Nord GmbH began operations in Emil-Sommer-Straße in Bremen. On 16 January 2013, the company was renamed InphA GmbH and the institute underwent a …
As part of the Global Health Protection Programme (GHPP) of the Federal Ministry of Health, InphA GmbH has been training staff from quality control laboratories of African drug regulatory authorities …
InphA GmbH is conducting a project in cooperation with the World Health Organisation (WHO) to revise monographs of the International Pharmacopoeia. The International Pharmacopoeia is a collection of regulations for …